Skip to content

Exploratory Clinical Trial on the Efficacy of Traditional Chinese Medicine Formulas in the Treatment of Sepsis

Exploratory Clinical Trial on the Efficacy of Traditional Chinese Medicine Formulas in the Treatment of Sepsis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001374
Enrollment
Unknown
Registered
2025-07-09
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Routine treatment :Standard Western medical treatment for sepsis
Routine treatment + NF101 TCM intervention group:Routine treatment + NF101 TCM intervention
Routine treatment + NF102 TCM intervention group:Routine treatment + NF102 TCM intervention

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with sepsis within 48 hours, with the diagnosis of sepsis meeting the Sepsis-3.0 diagnostic criteria, namely confirmed or suspected infection and a SOFA score of =2; (2) SOFA score: 2–13; (3) Aged between 18 and 85 years.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating female patients; (2) Patients who develop stress-related gastrointestinal ulcers, gastrointestinal bleeding, or other conditions requiring fasting during the study; or patients in whom a nasogastric or nasojejunal tube cannot be inserted; (3) Patients with serious underlying diseases, including advanced malignant tumors, hematologic malignancies, acquired immunodeficiency syndrome, or neutropenia; (4) Patients with severe hepatic or renal dysfunction, defined as an individual SOFA subscore of =3 for liver or kidney function; (5) Patients who have undergone organ transplantation within the past 6 months; (6) Patients who have participated in another clinical drug study within the past 1 month; (7) Patients with a history of allergy to traditional Chinese medicine; (8) Patients who refuse to sign the informed consent form; (9) Patients who have used Xuebijing Injection, Shenfu Injection, Shengmai Injection, Shenmai Injection, or other traditional Chinese medicine injections that may affect the efficacy evaluation of this study within 48 hours prior to randomization.

Design outcomes

Secondary

MeasureTime frame
SOFA change trajectory;Blood coagulation function;Total length of hospital stay;28-day organ support-free days;In-hospital mortality;28-day ICU-free days;Complete blood count;Arterial blood gas analysis;28-day all-cause mortality;ICU mortality;Inflammatory markers;

Primary

MeasureTime frame
SOFA score;

Countries

China

Contacts

Public ContactLi Kong

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

konglizy2@163.com028-85164187

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026